In a recent statement issued by the office of Florida Surgeon General Dr. Joseph Ladapo, a call for the halt in the use of COVID-19 mRNA vaccines was made due to the discovery of DNA contaminants in the vaccine vials. This revelation has raised concerns about the potential integration of vaccine DNA with the human genome.
Dr. Ladapo explained his decision to call for a halt on the Jan. 12 episode of EpochTV’s “American Thought Leaders.” He highlighted that while there are existing safety concerns with COVID mRNA vaccines, the discovery of DNA contaminants is “beyond the pale.” DNA is a common contaminant in biological products, but it typically doesn't pose a problem. However, since mRNA vaccines use lipid nanoparticles to deliver mRNA directly into cells, there is a possibility that DNA contaminants could also enter cells and integrate with the human genome.
This concern about DNA integration in the human genome has led Dr. Ladapo to send a letter to FDA commissioner Dr. Robert Califf and CDC director Dr. Mandy Cohen, asking for risk assessments regarding vaccine DNA integration into human DNA. Specifically, he questioned whether assessments have been done on DNA integration in reproductive cells and whether the current levels of DNA residuals are acceptable under FDA standards.
However, prominent officials at the FDA disagree with Dr. Ladapo's concerns. They argue that there is no evidence to suggest that vaccine DNA integrates with the human genome. This disagreement highlights the ongoing debate surrounding the safety and potential long-term effects of COVID vaccines.
In addition to concerns about DNA contaminants, newly published information reveals that certain batches of COVID-19 vaccines have caused significantly more adverse events than others. Data obtained by the Informed Consent Action Network through Freedom of Information Act requests from the CDC shows that some batches were linked to as many as 1,650 serious problems, while others produced zero reported issues.
This data contradicts a previous statement from the U.S. Department of Health and Human Services (HHS) to Sen. Ron Johnson, which claimed that there was no unusual concentration of reports with a single lot or small group of lots. This discrepancy raises questions about the transparency and accuracy of vaccine information provided by government agencies.
Sen. Johnson expressed concern over the newly disclosed data, stating that it provides strong evidence that the vaccine manufacturing process was not in control. He accused the CDC and FDA of withholding vital information from Congress and the American people.
Both the CDC and FDA have received Sen. Johnson's letter but have yet to respond. This further adds to the growing skepticism surrounding the handling and reporting of adverse events related to COVID vaccines.
